Production (Stage)
Astrana Health, Inc.
ASTH
$24.29
-$0.18-0.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.21M | 13.98M | 14.82M | 21.97M | 32.86M |
| Total Other Revenue | 2.24B | 2.02B | 1.71B | 1.57B | 1.42B |
| Total Revenue | 2.25B | 2.03B | 1.72B | 1.59B | 1.45B |
| Cost of Revenue | 1.98B | 1.76B | 1.46B | 1.33B | 1.21B |
| Gross Profit | 268.76M | 271.39M | 259.89M | 259.20M | 241.07M |
| SG&A Expenses | 159.29M | 154.11M | 150.43M | 142.03M | 130.14M |
| Depreciation & Amortization | 29.68M | 27.93M | 24.70M | 21.74M | 18.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.17B | 1.95B | 1.64B | 1.50B | 1.36B |
| Operating Income | 79.79M | 89.35M | 84.76M | 95.42M | 92.38M |
| Income Before Tax | 66.42M | 80.82M | 83.64M | 94.84M | 94.43M |
| Income Tax Expenses | 27.13M | 30.89M | 26.02M | 28.23M | 32.21M |
| Earnings from Continuing Operations | 39.29 | 49.93 | 57.62 | 66.61 | 62.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.29M | -6.78M | 4.84M | 1.81M | 197.00K |
| Net Income | 35.01M | 43.15M | 62.46M | 68.42M | 62.42M |
| EBIT | 79.79M | 89.35M | 84.76M | 95.42M | 92.38M |
| EBITDA | 109.47M | 117.28M | 109.46M | 117.16M | 110.93M |
| EPS Basic | 0.73 | 0.90 | 1.31 | 1.45 | 1.33 |
| Normalized Basic EPS | 0.78 | 0.91 | 1.14 | 1.25 | 1.21 |
| EPS Diluted | 0.72 | 0.89 | 1.30 | 1.44 | 1.32 |
| Normalized Diluted EPS | 0.78 | 0.90 | 1.13 | 1.24 | 1.20 |
| Average Basic Shares Outstanding | 190.11M | 188.90M | 190.09M | 188.95M | 187.81M |
| Average Diluted Shares Outstanding | 191.39M | 190.24M | 191.42M | 190.12M | 188.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 15.58% | 0.22% | 95.91% | 90.86% | 99.60% |